Effects of ketoconazole or rifampin on the pharmacokinetics of tivozanib hydrochloride, a vascular endothelial growth factor receptor tyrosine kinase inhibitor-Reference-Cited by-同舟云学术

Effects of ketoconazole or rifampin on the pharmacokinetics of tivozanib hydrochloride, a vascular endothelial growth factor receptor tyrosine kinase inhibitor

Published:2014-10-01 Issue:2 Volume:4 Page:137-142
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:

Author:

Cotreau Monette M.¹,Siebers Nicholas M.²³,Miller James¹,Strahs Andrew L.¹,Slichenmyer William¹

Affiliation:

1. AVEO Oncology; Cambridge MA USA

2. Covance; Madison WI USA

3. Covance; Daytona FL USA

Funder

AVEO Oncology and Astellas

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpdd.145/fullpdf

Reference22 articles.

1. The biology of VEGF and its receptors;Ferrera;Nat Med.,2003

2. Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis;Schoenleber;Br J Cancer.,2009

3. Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis;Zhan;J Thorac Oncol.,2009

4. Targeting the tumor microenvironment: focus on angiogenesis;Fan;J Oncol.,2012

5. Sorafenib for the treatment of advanced renal cell carcinoma;Kane;Clin Cancer Res.,2006

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro demonstration of antedrug mechanism of a pharmacokinetic booster to improve CYP3A4 substrates by CYP3A4-mediated metabolism inhibition;Drug Metabolism and Pharmacokinetics;2024-06

2. Predictability of human exposure by human‐CYP3A4‐transgenic mouse models: A meta‐analysis;Clinical and Translational Science;2023-12

3. HPLC methods for studying pharmacokinetics of tivozanib and in vitro metabolic interaction with dexamethasone in rat;Journal of Pharmaceutical and Biomedical Analysis;2023-08

4. Tivozanib: A New Hope for Treating Renal Cell Carcinoma;Anti-Cancer Agents in Medicinal Chemistry;2023-03

5. Involvement of Transporters in Intestinal Drug–Drug Interactions of Oral Targeted Anticancer Drugs Assessed by Changes in Drug Absorption Time;Pharmaceutics;2022-11-17